Brief: Venus Medtech Hangzhou To Sell 157,800 Series B Preferred Shares Of Valgen Holding
29/12/2025 13:47
Dec 29 (Reuters) - Venus Medtech Hangzhou 2500.HK: UNIT TO SELL 157,800 SERIES B PREFERRED SHARES OF VALGEN HOLDING FOR US$15 MILLION Further company coverage: 2500.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Venus Medtech (Hangzhou)
See all newsBrief: Venus Medtech Hangzhou To Issue 184.5 Million Shares And HK$379.7 Million Convertible Bonds
Brief: Venus Medtech Hangzhou Says Six-Month Revenue Rmb135.5 Million
Brief: Venus Medtech Hangzhou Says Liqiao Ma Resigns As Executive Director
Brief: Venus Medtech Hangzhou Logs FY Revenue RMB 306.8 Mln
Brief: Venus Medtech Says Unaware Of Any Info Needing Disclosure To Avoid False Market